ID   GATA1_RAT               Reviewed;         413 AA.
AC   P43429;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   29-MAY-2024, entry version 174.
DE   RecName: Full=Erythroid transcription factor;
DE   AltName: Full=Eryf1;
DE   AltName: Full=GATA-binding factor 1;
DE            Short=GATA-1;
DE            Short=GF-1;
DE   AltName: Full=NF-E1 DNA-binding protein;
GN   Name=Gata1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=Fetal liver;
RX   PubMed=7957872; DOI=10.1016/0014-5793(94)01062-5;
RA   Matsuda K., Kobune Y., Noda C., Ichihara A.;
RT   "Expression of GATA-binding transcription factors in rat hepatocytes.";
RL   FEBS Lett. 353:269-272(1994).
CC   -!- FUNCTION: Transcriptional activator or repressor which probably serves
CC       as a general switch factor for erythroid development. It binds to DNA
CC       sites with the consensus sequence 5'-[AT]GATA[AG]-3' within regulatory
CC       regions of globin genes and of other genes expressed in erythroid
CC       cells. Activates the transcription of genes involved in erythroid
CC       differentiation of K562 erythroleukemia cells, including HBB, HBG1/2,
CC       ALAS2 and HMBS. {ECO:0000250|UniProtKB:P15976}.
CC   -!- SUBUNIT: Interacts (via the N-terminal zinc finger) with ZFPM1.
CC       Interacts with GFI1B. Interacts with PIAS4; the interaction enhances
CC       sumoylation and represses the transactivational activity in a
CC       sumoylation-independent manner. Interacts with LMCD1. Interacts with
CC       BRD3 (By similarity). Interacts with CREBBP; the interaction stimulates
CC       acetylation and transcriptional activity in vivo. Interacts with MED1,
CC       CCAR1 and CALCOCO1 (By similarity). Interacts with EP300 (By
CC       similarity). Interacts with CEBPE (By similarity).
CC       {ECO:0000250|UniProtKB:P15976, ECO:0000250|UniProtKB:P17679}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Erythrocytes, and fetal hepatocytes.
CC       {ECO:0000269|PubMed:7957872}.
CC   -!- DOMAIN: The two fingers are functionally distinct and cooperate to
CC       achieve specific, stable DNA binding. The first finger is necessary
CC       only for full specificity and stability of binding, whereas the second
CC       one is required for binding (By similarity). {ECO:0000250}.
CC   -!- PTM: Highly phosphorylated on serine residues. Phosphorylation on Ser-
CC       310 is enhanced on erythroid differentiation. Phosphorylation on Ser-
CC       142 promotes sumoylation on Lys-137 (By similarity). {ECO:0000250}.
CC   -!- PTM: Sumoylation on Lys-137 is enhanced by phosphorylation on Ser-142
CC       and by interaction with PIAS4. Sumoylation with SUMO1 has no effect on
CC       transcriptional activity (By similarity). {ECO:0000250}.
CC   -!- PTM: Acetylated at 2 conserved lysine-rich motifs by CREBBP in vitro.
CC       Acetylation does not affect DNA-binding in vitro but is essential to
CC       induce erythroid differentiation and for binding chromatin in vivo.
CC       Acetylated on Lys-233, Lys-245 Lys-246 by EP300 (By similarity).
CC       {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D13518; BAA02735.1; -; mRNA.
DR   PIR; S48756; S48756.
DR   RefSeq; NP_036896.1; NM_012764.1.
DR   RefSeq; XP_017457744.1; XM_017602255.1.
DR   AlphaFoldDB; P43429; -.
DR   SMR; P43429; -.
DR   STRING; 10116.ENSRNOP00000038111; -.
DR   PhosphoSitePlus; P43429; -.
DR   PaxDb; 10116-ENSRNOP00000038111; -.
DR   Ensembl; ENSRNOT00000075082.3; ENSRNOP00000067336.1; ENSRNOG00000047663.3.
DR   Ensembl; ENSRNOT00055048355; ENSRNOP00055039763; ENSRNOG00055027943.
DR   Ensembl; ENSRNOT00060040056; ENSRNOP00060033058; ENSRNOG00060023142.
DR   Ensembl; ENSRNOT00065018341; ENSRNOP00065014011; ENSRNOG00065011306.
DR   GeneID; 25172; -.
DR   KEGG; rno:25172; -.
DR   UCSC; RGD:2663; rat.
DR   AGR; RGD:2663; -.
DR   CTD; 2623; -.
DR   RGD; 2663; Gata1.
DR   eggNOG; KOG1601; Eukaryota.
DR   GeneTree; ENSGT00940000161156; -.
DR   HOGENOM; CLU_027524_1_1_1; -.
DR   InParanoid; P43429; -.
DR   OMA; YSKTGLY; -.
DR   OrthoDB; 685518at2759; -.
DR   PhylomeDB; P43429; -.
DR   TreeFam; TF315391; -.
DR   Reactome; R-RNO-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-RNO-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-RNO-983231; Factors involved in megakaryocyte development and platelet production.
DR   PRO; PR:P43429; -.
DR   Proteomes; UP000002494; Chromosome X.
DR   Bgee; ENSRNOG00000025534; Expressed in spleen and 3 other cell types or tissues.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0032993; C:protein-DNA complex; ISO:RGD.
DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.
DR   GO; GO:0017053; C:transcription repressor complex; ISO:RGD.
DR   GO; GO:0070742; F:C2H2 zinc finger domain binding; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; IDA:RGD.
DR   GO; GO:0031490; F:chromatin DNA binding; ISS:UniProtKB.
DR   GO; GO:0000987; F:cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; IDA:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISO:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0002039; F:p53 binding; ISO:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISO:RGD.
DR   GO; GO:0001223; F:transcription coactivator binding; ISO:RGD.
DR   GO; GO:0001221; F:transcription coregulator binding; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0031100; P:animal organ regeneration; IDA:RGD.
DR   GO; GO:0030221; P:basophil differentiation; ISO:RGD.
DR   GO; GO:0030282; P:bone mineralization; ISO:RGD.
DR   GO; GO:0048468; P:cell development; ISO:RGD.
DR   GO; GO:0045165; P:cell fate commitment; IBA:GO_Central.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0007267; P:cell-cell signaling; ISO:RGD.
DR   GO; GO:0071320; P:cellular response to cAMP; IEP:RGD.
DR   GO; GO:0071372; P:cellular response to follicle-stimulating hormone stimulus; IEP:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IDA:RGD.
DR   GO; GO:0097028; P:dendritic cell differentiation; ISO:RGD.
DR   GO; GO:0035162; P:embryonic hemopoiesis; ISO:RGD.
DR   GO; GO:0030222; P:eosinophil differentiation; ISO:RGD.
DR   GO; GO:0035854; P:eosinophil fate commitment; ISO:RGD.
DR   GO; GO:0048821; P:erythrocyte development; ISO:RGD.
DR   GO; GO:0030218; P:erythrocyte differentiation; ISO:RGD.
DR   GO; GO:0048873; P:homeostasis of number of cells within a tissue; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0008584; P:male gonad development; ISO:RGD.
DR   GO; GO:0030219; P:megakaryocyte differentiation; ISO:RGD.
DR   GO; GO:0033028; P:myeloid cell apoptotic process; ISO:RGD.
DR   GO; GO:0030099; P:myeloid cell differentiation; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0030502; P:negative regulation of bone mineralization; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; ISO:RGD.
DR   GO; GO:0033033; P:negative regulation of myeloid cell apoptotic process; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0033687; P:osteoblast proliferation; ISO:RGD.
DR   GO; GO:0070527; P:platelet aggregation; ISO:RGD.
DR   GO; GO:0030220; P:platelet formation; ISO:RGD.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IMP:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0045648; P:positive regulation of erythrocyte differentiation; ISO:RGD.
DR   GO; GO:0043306; P:positive regulation of mast cell degranulation; IMP:RGD.
DR   GO; GO:0033690; P:positive regulation of osteoblast proliferation; ISO:RGD.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0060319; P:primitive erythrocyte differentiation; ISO:RGD.
DR   GO; GO:0010724; P:regulation of definitive erythrocyte differentiation; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; TAS:RGD.
DR   GO; GO:0010559; P:regulation of glycoprotein biosynthetic process; ISO:RGD.
DR   GO; GO:0010725; P:regulation of primitive erythrocyte differentiation; ISO:RGD.
DR   GO; GO:0060009; P:Sertoli cell development; IEP:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   CDD; cd00202; ZnF_GATA; 2.
DR   Gene3D; 3.30.50.10; Erythroid Transcription Factor GATA-1, subunit A; 2.
DR   InterPro; IPR039355; Transcription_factor_GATA.
DR   InterPro; IPR000679; Znf_GATA.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   PANTHER; PTHR10071:SF190; ERYTHROID TRANSCRIPTION FACTOR; 1.
DR   PANTHER; PTHR10071; TRANSCRIPTION FACTOR GATA FAMILY MEMBER; 1.
DR   Pfam; PF00320; GATA; 2.
DR   PRINTS; PR00619; GATAZNFINGER.
DR   SMART; SM00401; ZnF_GATA; 2.
DR   SUPFAM; SSF57716; Glucocorticoid receptor-like (DNA-binding domain); 2.
DR   PROSITE; PS00344; GATA_ZN_FINGER_1; 2.
DR   PROSITE; PS50114; GATA_ZN_FINGER_2; 2.
PE   2: Evidence at transcript level;
KW   Acetylation; Activator; DNA-binding; Isopeptide bond; Metal-binding;
KW   Nucleus; Phosphoprotein; Reference proteome; Repeat; Repressor;
KW   Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..413
FT                   /note="Erythroid transcription factor"
FT                   /id="PRO_0000083399"
FT   ZN_FING         204..228
FT                   /note="GATA-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00094"
FT   ZN_FING         258..282
FT                   /note="GATA-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00094"
FT   REGION          109..128
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          200..330
FT                   /note="Interaction with MED1 and CCAR1"
FT                   /evidence="ECO:0000250|UniProtKB:P15976"
FT   REGION          203..222
FT                   /note="Required for interaction with ZFPM1"
FT                   /evidence="ECO:0000250"
FT   REGION          249..315
FT                   /note="Interaction with CALCOCO1"
FT                   /evidence="ECO:0000250|UniProtKB:P15976"
FT   REGION          297..325
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          391..413
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        394..413
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         26
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P17679"
FT   MOD_RES         49
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P17679"
FT   MOD_RES         72
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P17679"
FT   MOD_RES         142
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15976"
FT   MOD_RES         178
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P17679"
FT   MOD_RES         187
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P17679"
FT   MOD_RES         233
FT                   /note="N6-acetyllysine; by EP300"
FT                   /evidence="ECO:0000250|UniProtKB:P15976"
FT   MOD_RES         245
FT                   /note="N6-acetyllysine; by EP300"
FT                   /evidence="ECO:0000250|UniProtKB:P15976"
FT   MOD_RES         246
FT                   /note="N6-acetyllysine; by CREBBP"
FT                   /evidence="ECO:0000250|UniProtKB:P17679"
FT   MOD_RES         246
FT                   /note="N6-acetyllysine; by EP300"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         252
FT                   /note="N6-acetyllysine; by CREBBP"
FT                   /evidence="ECO:0000250|UniProtKB:P17679"
FT   MOD_RES         308
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17679"
FT   MOD_RES         310
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P17679"
FT   MOD_RES         312
FT                   /note="N6-acetyllysine; by CREBBP"
FT                   /evidence="ECO:0000250|UniProtKB:P17679"
FT   MOD_RES         314
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17679"
FT   MOD_RES         315
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P17679"
FT   CROSSLNK        137
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   413 AA;  42871 MW;  9BE4120FCF8269BB CRC64;
     MDFPGLGALG TSEPLPQFVD SALVSSTSDS AGFFSSGPES LDTASSSTSP NAATAAATAL
     AYYREAEAYR HSPVFQVYPL LNSMEGIPGS SPYASWAYSK TALYPASTVC PSHEDAPSQT
     LEDPDGKNNN TFLETLKTER LSPDLLTLGT ALPTSLPVTS SAYGGADFPS PFFSPTGSPL
     SSAAYSSPKF HGSLPLAPCE ARECVNCGAT ATPLWRRDRT GHYLCNACGL YHKMNGQNRP
     LIRPKKRMIV SKRAGTQCTN CQTTTTTLWR RNASGDPVCN ACGLYYKLHQ VNRPLTMRKD
     GIQTRNRKAS GKGKKKRGSS LAGAGAAEGP AGGFMVVAGG SSSGNCGEVA PGLTLGTAGT
     AHLYQGLGPV VLSGPVSHLM SFPGPLLGSP TASFPTGPVP TTTSTSVVSP LSS
//
